2,359
Views
1
CrossRef citations to date
0
Altmetric
Urology

Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States

ORCID Icon, , ORCID Icon &
Pages 1092-1100 | Received 30 Sep 2021, Accepted 18 Aug 2022, Published online: 09 Sep 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.